anurajms/meta_analysis huggingface dataset:
Provide patient population that should be included in the study
Exercise‐based cardiac rehabilitation for coronary heart disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Myocardial Infarction 4. Middle Aged 45-64 years 5. Angina Pectoris 6. Young Adult 19-24 years 7. Coronary Artery Disease 8. Coronary Revascularisation 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Beta‐blockers in patients without heart failure after myocardial infarction
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Myocardial Infarction 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease: a network meta‐analysis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Coronary Heart Disease 5. Young Adult 19-24 years 6. Heart Failure 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Anticoagulants for acute ischaemic stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Infant 1 to 23 mo 5. Young Adult 19-24 years 6. Ischemic Stroke 7. Birth to 1 mo 8. Aged 65-79 years 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Interrupted versus uninterrupted anticoagulation therapy for catheter ablation in adults with arrhythmias
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Cardiac Arrhythmia 5. Ablation Operation For Arrhythmia 6. Young Adult 19-24 years 7. Aged 65-79 years 8. Anticoagulant therapy 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Local versus general anaesthesia for carotid endarterectomy
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Carotid Endarterectomy 6. Aged 65-79 years
Provide patient population that should be included in the study
Ultrasound guidance for arterial (other than femoral) catheterisation in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Procedure on artery 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Treatment for telangiectasias and reticular veins
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Reticular Varices 6. Aged 65-79 years 7. Telangiectasia
Provide patient population that should be included in the study
Pharmacotherapy for hypertension‐induced left ventricular hypertrophy
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Hypertensive Left Ventricular Hypertrophy 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Hybrid repair versus conventional open repair for aortic arch dissection
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aortic dissection 6. Aged 65-79 years
Provide patient population that should be included in the study
Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. End Stage Kidney Disease 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Stem cell therapy for dilated cardiomyopathy
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years 7. Dilated Cardiomyopathy
Provide patient population that should be included in the study
Graduated compression stockings for the initial treatment of varicose veins in people without venous ulceration 
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Varicose Veins 6. Aged 65-79 years
Provide patient population that should be included in the study
Cilostazol for intermittent claudication
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Intermittent claudication 6. Aged 65-79 years
Provide patient population that should be included in the study
Retroperitoneal versus transperitoneal approach for elective open abdominal aortic aneurysm repair
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Abdominal Aortic Aneurysm 6. Aged 65-79 years
Provide patient population that should be included in the study
Endovascular thrombectomy and intra‐arterial interventions for acute ischaemic stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Artery revascularisation 5. Young Adult 19-24 years 6. Ischemic Stroke 7. Aged 65-79 years
Provide patient population that should be included in the study
Slow versus fast subcutaneous heparin injections for prevention of bruising and site pain intensity
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years
Provide patient population that should be included in the study
Hybrid repair versus conventional open repair for thoracic aortic arch aneurysms
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Aneurysm Of Thoracic Aorta
Provide patient population that should be included in the study
Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chronic heart failure with preserved ejection fraction
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Heart Failure 6. Left Ventricular Ejection Fraction 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Anticoagulation versus placebo for heart failure in sinus rhythm
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Heart Failure 6. Sinus Rhythm 7. Aged 65-79 years
Provide patient population that should be included in the study
Vasodilators for primary Raynaud's phenomenon
1. Raynaud's Phenomenon
Provide patient population that should be included in the study
Fludrocortisone for orthostatic hypotension
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Infant 1 to 23 mo 5. Pure Autonomic Failure 6. Orthostatic Hypotension 7. Aged 65-79 years 8. Adolescent 13-18 years 9. Adult 19-44 years 10. Autonomic Neuropathy 11. Middle Aged 45-64 years 12. Peripheral Nerve Disease 13. Young Adult 19-24 years 14. Birth to 1 mo
Provide patient population that should be included in the study
Exercise‐based cardiac rehabilitation for adults after heart valve surgery
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Heart Valve Replacement 5. Young Adult 19-24 years 6. Operation On Heart Valve 7. Heart Valve Disorder 8. Aged 65-79 years
Provide patient population that should be included in the study
Endoluminal interventions versus surgical interventions for stenosis in vein grafts following infrainguinal bypass
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Infrainguinal arterial bypass 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Vascular Graft Stenosis 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Thrombolytic therapy for pulmonary embolism
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pulmonary Embolism 6. Aged 65-79 years
Provide patient population that should be included in the study
Mobile phone‐based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years
Provide patient population that should be included in the study
Antibiotics for secondary prevention of coronary heart disease
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Coronary Heart Disease 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Surgical and radiological interventions for treating symptomatic extracranial cervical artery dissection
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Extracranial caratoid artery dissection 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Vertebral Artery Dissection
Provide patient population that should be included in the study
Long‐term effects of weight‐reducing drugs in people with hypertension
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Essential Hypertension 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Blood pressure targets in adults with hypertension
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Hypertensive disorder
Provide patient population that should be included in the study
Trypanocidal drugs for late‐stage, symptomatic Chagas disease (Trypanosoma cruzi infection)
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Chagas' Disease With Heart Involvement 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Angioplasty versus stenting for iliac artery lesions
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Iliac Artery Occlusion 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Low Cardiac Output Syndrome 6. Cardiogenic Shock 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Ivabradine as adjuvant treatment for chronic heart failure
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Chronic Heart Failure 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Essential Hypertension 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Electromechanical‐assisted training for walking after stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Cardiovascular disease 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Pentoxifylline for intermittent claudication
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Intermittent claudication 6. Aged 65-79 years
Provide patient population that should be included in the study
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Antiphospholipid Syndrome 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Vena caval filters for the prevention of pulmonary embolism
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pulmonary Embolism 6. Aged 65-79 years 7. Deep Venous Thrombosis
Provide patient population that should be included in the study
Atherectomy for peripheral arterial disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Peripheral Arterial Disease 6. Aged 65-79 years
Provide patient population that should be included in the study
Motor imagery for gait rehabilitation after stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Subarachnoid Hemorrhage 7. Aged 65-79 years
Provide patient population that should be included in the study
Presurgery exercise‐based conditioning interventions (prehabilitation) in adults undergoing lower limb surgery for peripheral arterial disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Vascular Surgical Procedure On Lower Limb 6. Peripheral Arterial Disease 7. Aged 65-79 years
Provide patient population that should be included in the study
Alcohol intake reduction for controlling hypertension
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Essential Hypertension 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Time course for blood pressure lowering of beta‐blockers with partial agonist activity
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Hypertensive disorder
Provide patient population that should be included in the study
Citicoline for treating people with acute ischemic stroke
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Ischemic Stroke 8. Aged 65-79 years 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Modes of exercise training for intermittent claudication
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Intermittent claudication 5. Aged 65-79 years
Provide patient population that should be included in the study
Setting and techniques for monitoring blood pressure during pregnancy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Postpartum 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
mHealth education interventions in heart failure
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Chronic Heart Failure 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Effect of alcohol on blood pressure
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Surgery for small asymptomatic abdominal aortic aneurysms
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Abdominal Aortic Aneurysm 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Mechanical assist devices for acute cardiogenic shock
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Cardiogenic Shock 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Mental practice for treating upper extremity deficits in individuals with hemiparesis after stroke
1. Aged 80 and over 80+ years 2. Edema Of The Upper Extremity 3. Hemiparesis 4. Adult 19-44 years 5. Stroke 6. Middle Aged 45-64 years 7. Young Adult 19-24 years 8. Aged 65-79 years
Provide patient population that should be included in the study
A comparison of different antibiotic regimens for the treatment of infective endocarditis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Adolescent 13-18 years 11. Infective Endocarditis
Provide patient population that should be included in the study
Anti‐inflammatory therapy for preventing stroke and other vascular events after ischaemic stroke or transient ischaemic attack
1. Ischemic Stroke 2. Transient Ischemia
Provide patient population that should be included in the study
Pharmacological, psychological and non‐invasive brain stimulation interventions for preventing depression after stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Pharmacological treatment for Buerger's disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Thromboangiitis Obliterans
Provide patient population that should be included in the study
Interventions for sexual dysfunction following stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Sexual dysfunction 6. Young Adult 19-24 years 7. Aged 65-79 years
Provide patient population that should be included in the study
Transverse versus vertical groin incision for femoral artery approach
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Infant 1 to 23 mo 5. Cut-down femoral artery access 6. Aged 65-79 years 7. Adolescent 13-18 years 8. Vascular Surgery 9. Adult 19-44 years 10. Middle Aged 45-64 years 11. Open Surgical Procedure 12. Young Adult 19-24 years 13. Birth to 1 mo
Provide patient population that should be included in the study
Low molecular weight heparin for prevention of microvascular occlusion in digital replantation
1. Child, Preschool 2-5 years 2. Adult 19-44 years 3. Child 6-12 years 4. Reattachment Of Finger 5. Traumatic Amputation Of Toe 6. Middle Aged 45-64 years 7. Replantation Of Thumb 8. Reattachment Of Extremity Of Toe 9. Young Adult 19-24 years 10. Traumatic Amputation Of Digit Of Hand 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Treatment of distal deep vein thrombosis
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Adolescent 13-18 years 5. Deep Venous Thrombosis
Provide patient population that should be included in the study
Physical fitness training for stroke patients
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Advance care planning for adults with heart failure
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Heart Failure 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Carotid artery stenting versus endarterectomy for treatment of carotid artery stenosis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Infant 1 to 23 mo 5. Young Adult 19-24 years 6. Carotid artery stenosis 7. Aged 65-79 years
Provide patient population that should be included in the study
Anticoagulant treatment for subsegmental pulmonary embolism
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Subsegmental Pulmonary Embolism 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
First‐line combination therapy versus first‐line monotherapy for primary hypertension
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Essential Hypertension 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Dressings and topical agents for arterial leg ulcers
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Arteritic Leg Ulcer 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Motor neuroprosthesis for promoting recovery of function after stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Endovascular versus open repair of asymptomatic popliteal artery aneurysm
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Aneurysm Of Popliteal Artery 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Percutaneous Coronary Intervention 7. Adolescent 13-18 years 8. Acute Coronary Syndrome
Provide patient population that should be included in the study
Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aortic Valve Stenosis 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Beta‐blockers for suspected or diagnosed acute myocardial infarction
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Myocardial Infarction 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years 12. Acute Myocardial Infarction
Provide patient population that should be included in the study
Positive airway pressure therapy for the treatment of central sleep apnoea associated with heart failure
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Central Sleep Apnea Syndrome 5. Young Adult 19-24 years 6. Heart Failure 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Cognitive rehabilitation for attention deficits following stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Cognitive Deficit In Attention 6. Young Adult 19-24 years 7. Aged 65-79 years
Provide patient population that should be included in the study
Combined proximal descending aortic endografting plus distal bare metal stenting (PETTICOAT technique) versus conventional proximal descending aortic stent graft repair for complicated type B aortic dissections
1. Aged 80 and over 80+ years 2. Type B Aortic Dissection 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing non‐cardiac surgery
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Surgery 5. Young Adult 19-24 years 6. General Anesthesia 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing cardiac surgery
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. General Anesthesia 6. Cardiac surgery 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Compression therapy for treating post‐thrombotic syndrome
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Post-thrombotic syndrome 6. Aged 65-79 years
Provide patient population that should be included in the study
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Atrial Fibrillation 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for visual field defects in people with stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Visual Field Defect 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Stem cell transplantation for ischemic stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Ischemic Stroke 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Prostacyclin for pulmonary arterial hypertension
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Pulmonary Arterial Hypertension 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Non‐invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years 7. Acute Cardiac Pulmonary Edema
Provide patient population that should be included in the study
Epidural analgesia for adults undergoing cardiac surgery with or without cardiopulmonary bypass
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Cardiac surgery 5. Cardiopulmonary Bypass
Provide patient population that should be included in the study
Calcium antagonists for acute ischemic stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Exercise‐based cardiac rehabilitation for adult patients with an implantable cardioverter defibrillator
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Implantable Defibrillator User 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Thoracic endovascular repair (TEVAR) versus open surgery for blunt traumatic thoracic aortic injury
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Injury Of Thoracic Aorta 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in‐stent restenosis of the femoropopliteal arteries
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aortic restenosis 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Clinically‐indicated replacement versus routine replacement of peripheral venous catheters
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Peripherally Inserted Central Venous Catheter In Situ 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Disease management interventions for heart failure
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Heart Failure 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb‐threatening ischaemia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Critical Limb Ischemia 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Implantable cardiac defibrillators for people with non‐ischaemic cardiomyopathy
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Cardiomyopathy 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Ezetimibe for the prevention of cardiovascular disease and all‐cause mortality events
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
First‐line drugs inhibiting the renin angiotensin system versus other first‐line antihypertensive drug classes for hypertension
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Essential Hypertension 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Stem cell therapy for treatment of thromboangiitis obliterans (Buerger's disease)
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Thromboangiitis Obliterans 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Gamma aminobutyric acid (GABA) receptor agonists for acute stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Percutaneous vascular interventions versus intravenous thrombolytic treatment for acute ischaemic stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Ischemic Stroke 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Very early versus delayed mobilisation after stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Hypertensive disorder 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Exercise‐based cardiac rehabilitation for people with implantable ventricular assist devices
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Cardiac assistance device user 5. Young Adult 19-24 years 6. Heart Failure 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Electromechanical and robot‐assisted arm training for improving activities of daily living, arm function, and arm muscle strength after stroke
1. Aged 80 and over 80+ years 2. Activities of Daily Living 3. Adult 19-44 years 4. Stroke 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Muscle Strength 8. Aged 65-79 years 9. Upper Limb Strength
Provide patient population that should be included in the study
Mechanical versus manual chest compressions for cardiac arrest
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Cardiac Arrest 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Endovascular coiling versus neurosurgical clipping for people with aneurysmal subarachnoid haemorrhage
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Subarachnoid Hemorrhage 6. Aged 65-79 years
Provide patient population that should be included in the study
Surgery versus thrombolysis for initial management of acute limb ischaemia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years 7. Acute Limb Ischaemia
Provide patient population that should be included in the study
Activity monitors for increasing physical activity in adult stroke survivors
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Blood pressure‐lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack
1. Aged 80 and over 80+ years 2. Intracerebral Hemorrhage 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Ischemic Stroke 7. Elevated Blood Pressure 8. Aged 65-79 years 9. Transient Cerebral Ischemia
Provide patient population that should be included in the study
Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non‐cardiac surgery
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Elective Surgery 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Antiphospholipid Antibodies Positive 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Mirror therapy for improving motor function after stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Paresis 7. Aged 65-79 years
Provide patient population that should be included in the study
Remote ischaemic conditioning for preventing and treating ischaemic stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Ischemic Stroke 6. Cerebral Ischemia 7. Small Vessel Cerebrovascular Disease 8. Cerebrovascular Disease 9. Aged 65-79 years
Provide patient population that should be included in the study
Controlled hypotension versus normotensive resuscitation strategy for people with ruptured abdominal aortic aneurysm
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Ruptured Abdominal Aortic Aneurysm 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Extracorporeal shock wave therapy for the healing and management of venous leg ulcers
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Venous leg ulcer 6. Aged 65-79 years
Provide patient population that should be included in the study
Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in people with coronary artery disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Arterial catheterization 5. Young Adult 19-24 years 6. Coronary Artery Disease 7. Aged 65-79 years 8. Percutaneous Coronary Intervention 9. Adolescent 13-18 years
Provide patient population that should be included in the study
First‐line drugs for hypertension
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Essential Hypertension 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Supervised exercise therapy versus home‐based exercise therapy versus walking advice for intermittent claudication
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Intermittent claudication 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Surgery 5. Young Adult 19-24 years 6. General Anesthesia 7. Aged 65-79 years
Provide patient population that should be included in the study
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Atrial Fibrillation 6. Aged 65-79 years
Provide patient population that should be included in the study
Fluvastatin for lowering lipids
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Treatment for superficial thrombophlebitis of the leg
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Superficial Thrombophlebitis 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Graft type for femoro‐popliteal bypass surgery
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Popliteal Artery Embolus
Provide patient population that should be included in the study
Pulmonary artery perfusion versus no perfusion during cardiopulmonary bypass for open heart surgery in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Cardiopulmonary Bypass 6. Aged 65-79 years 7. Open Heart Surgery
Provide patient population that should be included in the study
Exercise‐based cardiac rehabilitation for adults with stable angina
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stable Angina 4. Middle Aged 45-64 years 5. Coronary Heart Disease 6. Young Adult 19-24 years 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Antibiotic therapy for preventing infections in people with acute stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Hemorrhagic Cerebral Infarction 5. Young Adult 19-24 years 6. Ischemic Stroke 7. Aged 65-79 years
Provide patient population that should be included in the study
Prostanoids for critical limb ischaemia
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Critical Limb Ischemia 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Home versus in‐patient treatment for deep vein thrombosis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Adolescent 13-18 years 11. Deep Venous Thrombosis
Provide patient population that should be included in the study
Exercise for intermittent claudication
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Intermittent claudication 9. Atherosclerosis 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Unprovoked venous thromboembolism 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events
1. Ischaemic Heart Disease 2. Coronary Heart Disease 3. Peripheral Arterial Disease
Provide patient population that should be included in the study
Calcium channel blockers for primary and secondary Raynaud's phenomenon
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Raynaud's Phenomenon 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Thrombolysis for acute upper extremity deep vein thrombosis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Acute Deep Venous Thrombosis Of Upper Extremity
Provide patient population that should be included in the study
Pentasaccharides for the treatment of deep vein thrombosis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Deep Venous Thrombosis
Provide patient population that should be included in the study
Virtual reality for stroke rehabilitation
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Chronic Kidney Disease 10. Atrial Fibrillation 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Supraventricular Tachycardia 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Compression therapy for prevention of post‐thrombotic syndrome
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Deep Venous Thrombosis
Provide patient population that should be included in the study
Interventions for treating tuberculous pericarditis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Pericarditis tuberculous 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Adolescent 13-18 years 11. Acute Coronary Syndrome
Provide patient population that should be included in the study
Treadmill training and body weight support for walking after stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Abnormal Gait 6. Young Adult 19-24 years 7. Aged 65-79 years
Provide patient population that should be included in the study
Pharmacotherapy for hypertension in adults aged 18 to 59 years
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Essential Hypertension 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Blood pressure targets for hypertension in older adults
1. Aged 80 and over 80+ years 2. Essential Hypertension 3. Aged 65-79 years
Provide patient population that should be included in the study
Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Lower limb immobilization 6. Aged 65-79 years
Provide patient population that should be included in the study
Vitamin K antagonists versus low‐molecular‐weight heparin for the long term treatment of symptomatic venous thromboembolism
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Symptomatic Venous Thromboembolism 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Occupational therapy for adults with problems in activities of daily living after stroke
1. Aged 80 and over 80+ years 2. Activities of Daily Living 3. Adult 19-44 years 4. Stroke 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Aged 65-79 years
Provide patient population that should be included in the study
Early supported discharge services for people with acute stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Psychological interventions for acute pain after open heart surgery
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Postoperative Pain 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years 8. Open Heart Surgery
Provide patient population that should be included in the study
Niacin for primary and secondary prevention of cardiovascular events
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Growth factors for angiogenesis in peripheral arterial disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Peripheral Arterial Disease 6. Aged 65-79 years 7. Disorder Of Lower Extremity
Provide patient population that should be included in the study
Circuit class therapy for improving mobility after stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Abnormal Gait 6. Young Adult 19-24 years 7. Aged 65-79 years
Provide patient population that should be included in the study
Laparoscopic surgery for elective abdominal aortic aneurysm repair
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Abdominal Aortic Aneurysm 6. Aged 65-79 years